Metabolic Alterations in Fumarate Hydratase Deficient Cells - PowerPoint PPT Presentation

Metabolic Alterations in Fumarate Hydratase Deficient Cells Christian Frezza 1 MRC Cancer Unit, University of Cambridge, Cambridge, UK * Corresponding author: cf366@MRC-CU.cam.ac.uk 1

Metabolic Alterations in Fumarate Hydratase Deficient Cells Graphical Abstract Fe-S cluster biogenesis 2

Abstract: Mutations of the tricarboxylic acid cycle (TCA cycle) enzyme fumarate hydratase (FH) cause the hereditary cancer syndrome Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC). FH-deficient renal cancers are highly aggressive and metastasise even when small, leading to an abysmal clinical outcome. How these cells survive without FH and how they become transformed is still under investigation. Today, I will show our data on the metabolic reprogramming triggered by the loss of FH, which induces, amongst various changes, the fumarate-mediated succination of the iron-sulfur-cluster proteins ISCU1, NFU1, and Bola1/3. Of note, this post translational modification leads to defects in iron-sulfur cluster biogenesis and complex I deficiency. These results could help to explain the profound alteration of mitochondrial metabolism in cells that lack FH. Keywords: cancer metabolism, fumarate hydratase, mitochondria 3

• •

f u m a r a t e ( f m o l / c e l l ) 1 2 3 0 0 0 0 0 0 0 F h 1 f l / f l F h 1 - / - F h + F 1 - / - p h F 1 - / - h 1 + l o p F w h 1 Fh1 h i g h /  O C R ( p m o l / m i n g p r o t e i n ) 1 1 0 5 0 5 F h 1 f l / f F l h 1 - F / - h + 1 - F p / - h F 1 - h / - 1 + l o p F w h 1 Fh1 h i g h

5 m M G lutam ate 2  M R otenone 2  M A n tim yc in A 5 m M M alate 1 0 m M S u ccin ate 15 1 2 O C R (p m o l/m in /  g p r o te in ) O C R (p m o l/m in /  g p r o te in ) 1 0 10 8 6 high 5 4 2 0 0 0 10 20 30 0 1 0 2 0 3 0 T im e (m in ) T im e (m in ) 1 00  M TMPD + 20 mM 10 mM A z id e 2  M A n tim ycin 0 .5 m M D uroquinol A s c o rb a te 15 40 O C R (p m o l/m in /  g p r o te in ) O C R (p m o l/m in /  g p r o te in ) 30 10 20 5 10 0 0 0 4 8 12 16 20 24 28 32 0 10 20 30 T im e (m in ) T im e (m in )

B o v in e h e a rt m ito c h o n d ria l m e m b ra n e s N A D H :O 2 (  m o le s /m in /m g p r o te in ) 0 .0 0 .2 0 .4 0 .6 0 .8 c o n tro l 1 0 0 m M fu m a ra te B o v in e h e a rt m ito c h o n d ria l m e m b ra n e s N A D H :O 2 (  m o le s /m in /m g p r o te in ) 0 .0 0 .5 1 .0 1 .5 c o n tro l 5 m M M M F

protein protein Nature Reviews Cancer 12 , 564-571 (August 2012)

Acknowledgments Edoardo Gaude Marco Sciacovelli Key Collaborators: Mitochondrial Biology Unit, Cambridge Judy Hirst Hannah Bridges Cancer Research UK Cambridge Institute, Cambridge Petros Tyrakis and Marie Yurkovich Clive D’Santos and Eva Papachristou 29